Prochaska Judith J, Benowitz Neal L
Stanford Prevention Research Center, Department of Medicine, Stanford University, Stanford, California 94305; email:
Departments of Medicine and Bioengineering & Therapeutic Sciences, Division of Clinical Pharmacology and Experimental Therapeutics, University of California, San Francisco, California 94143; email:
Annu Rev Med. 2016;67:467-86. doi: 10.1146/annurev-med-111314-033712. Epub 2015 Aug 26.
The tobacco addiction treatment field is progressing through innovations in medication development, a focus on precision medicine, and application of new technologies for delivering support in real time and over time. This article reviews the evidence for combined and extended cessation pharmacotherapy and behavioral strategies including provider advice, individual counseling, group programs, the national quitline, websites and social media, and incentives. Healthcare policies are changing to offer cessation treatment to the broad population of smokers. With knowledge of the past and present, this review anticipates what is likely on the horizon in the clinical and public health effort to address tobacco addiction.
烟草成瘾治疗领域正通过药物研发创新、对精准医学的关注以及应用新技术来实时并长期提供支持而不断发展。本文回顾了联合及延长戒烟药物疗法和行为策略的证据,这些策略包括提供者建议、个体咨询、团体项目、国家戒烟热线、网站和社交媒体以及激励措施。医疗保健政策正在发生变化,以便为广大吸烟者提供戒烟治疗。基于对过去和现在的了解,本综述预测了在临床和公共卫生领域应对烟草成瘾的努力中可能出现的情况。